Search

Biotissue

Cryopreserved Amniotic Membrane for Severe Dry Eye Patients

Mark Milner, MD

Show Description +

Dr. Milner discusses how CAM can help with severe dry eye and neurotrophic patients. How treatment with PROKERA was associated with a dramatic reduction of all signs and symptoms at 1 month, which was maintained out to 3 months (the duration of the study). In addition to symptomatic relief and improved vision, CAM-C regenerated corneal nerves as measured by increased nerve density on confocal microscopy and increased corneal sensitivity, attesting to its regenerative mechanism of action.

Posted: 11/09/2020

Keywords:

Bio-Tissue

•

Cryopreserved Amniotic Membrane (CAM)

•

PROKERA

Up Next

Inflammation: The Root of OSD

Inflammation: The Root of OSD

Douglas Devries, OD

Next-Level Dry Eye Treatment

Next-Level Dry Eye Treatment

Damon Dierker, OD

How to Diagnose Mechanical Dry Eye

How to Diagnose Mechanical Dry Eye

Clifford Salinger, MD

How to Talk to the Patient About CCh

How to Talk to the Patient About CCh

Clifford Salinger, MD

Understanding the CCh Anatomy

Understanding the CCh Anatomy

Clifford Salinger, MD

Surgical Intervention of CCh

Surgical Intervention of CCh

Clifford Salinger, MD

Key Points of Diagnosing and Treating CCh Patients

Key Points of Diagnosing and Treating CCh Patients

Clifford Salinger, MD

BioTissue CCH Without Suture

BioTissue CCH Without Suture

Primary Pterygium Surgery with AmnioGraft (Neel Desai, MD)

Primary Pterygium Surgery with AmnioGraft (Neel Desai, MD)

Neel Desai, MD

How PROKERA Works

How PROKERA Works

Differences Between Cryopreserved and Dehydrated Amniotic Tissue

Differences Between Cryopreserved and Dehydrated Amniotic Tissue

David Kading, OD, FAAO, Derek Cunningham, OD

Optimize the Ocular Surface Prior to Cataract Surgery

Optimize the Ocular Surface Prior to Cataract Surgery

Gary Wortz, MD

New Treatment Option for Severe Dry Eye

New Treatment Option for Severe Dry Eye

You Should Have This in Your Therapeutic Toolbox

You Should Have This in Your Therapeutic Toolbox

David Kading, OD, Derek Cunningham, OD

The Science behind Regeneration

The Science behind Regeneration

Neel Desai, MD

Pearls for Pterygium Surgery

Pearls for Pterygium Surgery

Neel Desai, MD

Practice Economics of Pterygium Surgery

Practice Economics of Pterygium Surgery

Neel Desai, MD

Addressing Mechanically Induced Dry Eye

Addressing Mechanically Induced Dry Eye

Neel Desai, MD

Audience Q&A

Neel Desai, MD

The Secret Sauce in the Cryopreserved Amniotic Membrane

The Secret Sauce in the Cryopreserved Amniotic Membrane

Marguerite McDonald, MD, FACS

The Use of Cryopreserved Amniotic Membrane for Corneal Ulcers & Infectious Keratitis

The Use of Cryopreserved Amniotic Membrane for Corneal Ulcers & Infectious Keratitis

John D. Sheppard, MD

The Revised Treatment Protocol of Recurrent Corneal Erosion

The Revised Treatment Protocol of Recurrent Corneal Erosion

Clifford Salinger, MD

The Study of 10 Patients with Bi-Lateral EBMD

The Study of 10 Patients with Bi-Lateral EBMD

Neel R. Desai, MD

Back to All Videos

Cryopreserved Amniotic Membrane for Severe Dry Eye Patients

Mark Milner, MD

Dr. Milner discusses how CAM can help with severe dry eye and neurotrophic patients. How treatment with PROKERA was associated with a dramatic reduction of all signs and symptoms at 1 month, which was maintained out to 3 months (the duration of the study). In addition to symptomatic relief and improved vision, CAM-C regenerated corneal nerves as measured by increased nerve density on confocal microscopy and increased corneal sensitivity, attesting to its regenerative mechanism of action.

Posted: 11/09/2020

Keywords:

Bio-Tissue

•

Cryopreserved Amniotic Membrane (CAM)

•

PROKERA

Resources

Filter:

AmnioGraft Prokera

AmnioGraft Prokera

Early Intervention With

Early Intervention With

Early Intervention with Cryopreserved Amniotic Membrane: A Mindset

Impacting a Patients Quality

Impacting a Patients Quality

Impacting a patient’s quality of life – A PROKERA case study

Restoring Corneal Clarity

Restoring Corneal Clarity

Restoring Corneal Clarity: Cryopreserved Amniotic Membrane and Stromal HSV

Pterygium Surgery

Pterygium Surgery

Pterygium Surgery – The Thorn in Our Side

Reducing Pterygium Recurrence

Reducing Pterygium Recurrence

Reducing Pterygium Recurrence: Improve Surgical Outcomes with This Time-Saving Technique

Study Demonstrates Cryopreserved

Study Demonstrates Cryopreserved

Study Demonstrates Cryopreserved Amniotic Membrane Graft Reduces Recurrence After Pterygium Surgery

Prokera Consultative Sales Aid

Prokera Consultative Sales Aid

PROKERA Consultative Sales Ad

Cryotek Competitive Barrier

CryoTek Competitive Barrier Handler

A Safe Effective Procdedure

A Safe Effective Procdedure

A Safe, Effective Procedure for Conjunctivochalasis

Identifying Conjuctivochalasis

Identifying Conjuctivochalasis

Identifying Conjunctivochalasis: The Importance of Restoring the Tear Reservoir for Patients with T

Part 1 Conjuctivochaalsis

Part 1 Conjuctivochaalsis

Part 1: Conjunctivochalasis (CCH) Dry Eye: The Reservoir Restoration Procedure for CCH

Part 2 Conjuctivochalasis

Part 2 Conjuctivochalasis

Part 2: Conjunctivochalasis (CCH) Dry Eye: The Reservoir Restoration Procedure for CCH

Reservoir Restoration Technique

Reservoir Restoration Technique

Reservoir Restoration Technique for Conjunctivochalasis: A Solution for Mechanically Induced Dry Eye

Product Brochure

Product Brochure

BioTissue Product Brochure

OSSTC Program

OSSTC Program

OSSTC Program 2019

AmnioGraft Sales Aid

AmnioGraft Sales Aid

AmnioGraft Sales Aid

A CCh Case Study

A CCh Case Study

A CCh Case Study: Addressing the Real Cause of Conjunctivochalasis (CCH)

About Biotissue

Learn More: tissuetech.com

Follow Biotissue